Zhihua Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhihua Lu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Chunxi Wang
Department of Urology, The First Hospital of Jilin University, Changchun, China
1 shared publication - Donglu Wu
College of Life Science, Jilin University, Changchun City, Jilin 130012, China
1 shared publication - Jingji Jin
School of Life Sciences, Jilin University, Changchun, China
1 shared publication - Rui Zhang
College of Life Science, Jilin University, Changchun City, Jilin 130012, China
1 shared publication - Wentao Sun
Urology Department, The First Clinical Hospital, Jilin University, Changchun City, Jilin 130021, China
1 shared publication - Yong Cai
School of Life Sciences, Jilin University, Changchun, China
1 shared publication
Latest Publications
- Open Access
- 9 February 2013
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 32 (1) , 8
Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma
MYST1 (also known as hMOF), a member of the MYST family of histone acetyltransferases (HATs) as an epigenetic mark of active genes, is mainly responsible for histone H4K16 acetylation in the cells. Recent studies have shown that the abnormal gene expression of hMOF is involved in certain primary cancers. Here we examined the involvement of hMOF expression and histone H4K16 acetylation in primary renal cell carcinoma (RCC). Simultaneously, we investigated the correlation between the expression of hMOF and clear cell RCC (ccRCC) biomarker carbohydrase IX (CA9) in RCC.
- 9 February 2013
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 32 (1) , 8
Open AccessEpigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma
MYST1 (also known as hMOF), a member of the MYST family of histone acetyltransferases (HATs) as an epigenetic mark of active genes, is mainly responsible for histone H4K16 acetylation in the cells. Recent studies have shown that the abnormal gene expression of hMOF is involved in certain primary cancers. Here we examined the involvement of hMOF expression and histone H4K16 acetylation in primary renal cell carcinoma (RCC). Simultaneously, we investigated the correlation between the expression of hMOF and clear cell RCC (ccRCC) biomarker carbohydrase IX (CA9) in RCC.